Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 21, 1993
Grant Date -
N/A
app pub date -
Jan 31, 1992
filing date -
Jan 31, 1991
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A pharmaceutcial composition is provided for use in the prevention or treatment of viral infections caused by enveloped viruses. The composition comprises a fibroblast growth factor, a sulfated polysaccharide with antiviral activity, and one or more pharmaceutically acceptable carriers. The fibroblast growth factor may be a basic fibroblast growth factor or an analogue thereof, and the polysaccharide may be a carrageenan, heparin, dextran sulfate, pentosan polysulfate or a sulfated polysaccharides produced by marine algae belonging to the class of Rhodophyceae.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully